HBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives

Simply Wall St.04-01

HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624196865?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-04-01 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624196865","market":"nz","top_or_hot":-1,"title":"HBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives","media":"Simply Wall St.","content":"<div>\n<p>HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM Holdings (SEHK:2142) Net Margin Surge Challenges Bearish Earnings Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-01 20:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea","article_id":"2624196865","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-net-margin-surge-challenges-bearish-ea","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2624196865","pubTimestamp":1775046404,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings growth over the last 12 months. The company has seen revenue move from US$23.7 million and US$14.4 million in the first and second halves of FY 2024 to US$101.3 million in the first half of FY 2025, while basic EPS shifted from roughly US$0.002 in each FY 2024 half to just over US$0.09, setting up...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK4168":"多种金属与采矿","BK1574":"生物医药B类股","BK1583":"高瓴概念","02142":"和铂医药-B","HBM":"HudBay Minerals Inc"},"translate_title":"HBM Holdings(SEHK：2142)净利润飙升挑战看跌的盈利叙述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HBM":0.9,"02142":0.9},"content_text":"HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings growth over the last 12 months. The company has seen revenue move from US$23.7 million and US$14.4 million in the first and second halves of FY 2024 to US$101.3 million in the first half of FY 2025, while basic EPS shifted from roughly US$0.002 in each FY 2024 half to just over US$0.09, setting up a story of sharply higher profit margins and a stronger earnings base for investors to assess. See our full analysis for HBM Holdings. With the headline numbers on the table, the next step is to set these results against the market narratives around HBM Holdings to see which stories the latest margins support and which they start to challenge. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:2142 Earnings & Revenue History as at Apr 2026 AdvertisementNet margin at 57.8% on trailing US$158 million revenue  Over the trailing twelve months, HBM recorded total revenue of US$157.975 million and net income of US$91.333 million, which works out to a net profit margin of 57.8% compared with 7.3% in the prior year. What stands out for a bullish narrative is how this high margin lines up with the story of a platform company building earnings power, yet forecasts expecting earnings to decline by about 4.1% per year over the next three years point in a different direction.\n     Supporters can point to the swing in net income from US$2.778 million in the prior trailing period to US$91.333 million now as evidence that the business model can convert revenue into profit when conditions allow. At the same time, the forecast 4.9% annual revenue growth and projected earnings decline suggest recent profitability may not automatically repeat. Bullish investors need to factor this into how durable they think this margin profile is.    FY 2025 first half profit climbs to US$71.7 million  In the first half of FY 2025, HBM reported net income of US$71.718 million on revenue of US$101.315 million, compared with US$1.424 million and US$23.701 million in the first half of FY 2024 and US$1.354 million and US$14.399 million in the second half of FY 2024. Critics who focus on bearish angles often worry about the sustainability of such a sharp profit step up, and the numbers here give them plenty to scrutinize even while acknowledging the scale of the change.\n     On a per share basis, basic EPS moved from roughly US$0.0019 and US$0.0017 in the FY 2024 halves to about US$0.0931 in FY 2025 first half, which is a very large increase relative to the prior periods but sits alongside forecasts that earnings will decline over the next few years. Bears can also point to the data flagging shareholder dilution in the past year, which means part of the earnings story sits alongside a growing share count and reinforces their focus on how per share outcomes might look if profitability normalizes.    Investors who want to see how different scenarios around this earnings jump play out over time can compare more cautious and optimistic takes in the 📊 Read the what the Community is saying about HBM Holdings. P/E of 16.6x versus higher industry and peer averages  HBM is trading on a trailing P/E of 16.6x, compared with around 38x for the wider Asian biotech group and roughly 57.6x for its peer set, according to the provided data. Consensus style thinking often frames this as potential valuation appeal against the sector, yet the same dataset pairs that lower P/E with expectations for slower growth, which keeps the debate open rather than one sided.\n     The earnings multiple is set against trailing earnings that grew very rapidly year over year and a 5 year annualized earnings growth rate of 70.5%, figures that would usually attract interest when the P/E sits below industry and peers. However, with revenue growth forecast at 4.9% per year versus 8.5% for the Hong Kong market and earnings projected to decline by about 4.1% per year, investors weighing the 16.6x P/E have to decide how much weight to give the strong trailing numbers versus the softer outlook.    Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on HBM Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. With sentiment in this article leaning both optimistic and cautious, now is a good time to review the numbers yourself and decide where you stand. To weigh the positives against the concerns in one place, take a closer look at the 2 key rewards and 2 important warning signs. See What Else Is Out There HBM Holdings couples a 16.6x P/E and strong recent earnings with forecasts for earnings decline and slower revenue growth than the broader Hong Kong market. If that mix of solid results and softer outlook leaves you wanting more balanced prospects, compare it with companies screened as 253 high quality undervalued stocks.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if HBM Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624196865","isCrawlerRequest":true}